Encompass Health (MEX:EHC) Cyclically Adjusted Revenue per Share: MXN693.61 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:EHC Encompass Health Corp MEX:EHC
81 GF Score
Price MXN1,920.00
GF Value MXN1,782.98
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Encompass Health Cyclically Adjusted Revenue per Share?

Encompass Health MEX:EHC 81 Cyclically Adjusted Revenue per Share is MXN693.61 as of Jun. 2026. GuruFocus rates MEX:EHC with a GF Score™ of 81/100 and a GF Value™ of MXN1,782.98 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Encompass Health's adjusted revenue per share for the three months ended in Jun. 2026 was MXN278.730. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN693.61 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Encompass Health's average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Encompass Health was 35.80% per year. The lowest was -12.80% per year. And the median was 8.80% per year.

As of today (2026-08-15), Encompass Health's current stock price is MXN1920.00. Encompass Health's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was MXN693.61. Encompass Health's Cyclically Adjusted PS Ratio of today is 2.77.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Encompass Health was 2.46. The lowest was 1.07. And the median was 1.67.


Encompass Health  (MEX:EHC) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Encompass Health's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1920.00/693.61
=2.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Encompass Health was 2.46. The lowest was 1.07. And the median was 1.67.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Encompass Health Cyclically Adjusted Revenue per Share Related Terms


Encompass Health Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Encompass Health's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Encompass Health Cyclically Adjusted Revenue per Share Chart

Encompass Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 949.30 915.59 884.08 686.82 633.04

Encompass Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 537.79 526.97 633.04 712.23 693.61

MEX:EHC vs ENSG, UHS, PACS: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Encompass Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Encompass Health Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Encompass Health's Cyclically Adjusted PS Ratio falls into.


MEX:EHC
81GF Score
Encompass Health Corp MEX:EHC
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Encompass Health Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Encompass Health's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=278.73/333.9520*333.9520
=278.730

Current CPI (Jun. 2026) = 333.9520.

Encompass Health Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 177.404 241.428 245.392
201612 193.116 241.432 267.121
201703 182.033 243.801 249.344
201706 176.629 244.955 240.802
201709 179.940 246.819 243.463
201712 198.322 246.524 268.656
201803 191.180 249.554 255.836
201806 210.640 251.989 279.154
201809 199.695 252.439 264.177
201812 214.985 251.233 285.769
201903 218.690 254.202 287.299
201906 219.558 256.143 286.254
201909 230.707 256.759 300.068
201912 225.406 256.974 292.928
202003 278.268 258.115 360.026
202006 248.173 257.797 321.485
202009 259.586 260.280 333.062
202012 27.086 260.474 34.727
202103 251.004 264.877 316.461
202106 255.818 271.696 314.436
202109 207.426 274.310 252.526
202112 212.794 278.802 254.887
202203 210.496 287.504 244.503
202206 213.114 296.311 240.186
202209 218.063 296.808 245.352
202212 220.187 296.797 247.751
202303 207.296 301.836 229.353
202306 201.301 305.109 220.331
202309 207.326 307.789 224.949
202312 207.689 306.746 226.109
202403 213.705 312.332 228.498
202406 233.707 314.175 248.419
202409 260.545 315.301 275.957
202412 286.715 315.605 303.383
202503 291.625 319.799 304.531
202506 268.302 322.561 277.777
202509 264.942 324.800 272.407
202512 272.930 324.054 281.266
202603 284.400 330.213 287.620
202606 278.730 333.952 278.730

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN693.61 mean?
Encompass Health (MEX:EHC) has a Cyclically Adjusted Revenue per Share of MXN693.61 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Encompass Health and its competitors.
Is Encompass Health's Cyclically Adjusted Revenue per Share too high?
Encompass Health's current Cyclically Adjusted Revenue per Share is MXN693.61. Overall, Encompass Health has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's Cyclically Adjusted Revenue per Share compare to ENSG and UHS?
Encompass Health's Cyclically Adjusted Revenue per Share of MXN693.61 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Encompass Health and its competitors. Encompass Health's current Cyclically Adjusted Revenue per Share is MXN693.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN1,782.98, compared to a current price of MXN1,920.00 — trading 7.7% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN693.61. Encompass Health's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current Cyclically Adjusted Revenue per Share is MXN693.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Encompass Health (MEX:EHC) Overvalued in 2026?

Based on GuruFocus' analysis, Encompass Health stock appears to be overvalued. The current stock price of MXN1,920.00 is trading 7.7% above its estimated GF Value™ of MXN1,782.98. GuruFocus considers Encompass Health to be Significantly Overvalued.

Key valuation signals for MEX:EHC:

  • Cyclically Adjusted Revenue per Share: MXN693.61
  • GF Value™: MXN1,782.98 vs. price of MXN1,920.00 (7.7% above fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Encompass Health Business Description

Other Exchanges EHC:USA
Address 9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
81GF Score

Get the complete analysis for MEX:EHC

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,920.00
Price
MXN1,782.98
GF Value